Cited by 121SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.

A Comprehensive Review About SARS-CoV-2

Open access

Haque, SK Manirul, Ashwaq, Omar, Sarief, Abdulla, Azad John Mohamed, Abdul Kalam·2020·Future Virology

DOI 10.2217/fvl-2020-0124PMC PMC7664148

Open this paper in CoChat — free account

Abstract

The coronavirus disease (COVID-19) was first identified in China, December 2019. Since then, it has spread the length and breadth of the world at an unprecedented, alarming rate. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which causes COVID-19, has much in common with its closest homologs, SARS-CoV and Middle East respiratory syndrome-CoV. The virus-host interaction of SARS-CoV-2 uses the same receptor, ACE2, which is similar to that of SARS-CoV, which spreads through the respiratory tract. Patients with COVID-19 report symptoms including mild-to-severe fever, cough and fatigue; very few patients report gastrointestinal infections. There are no specific antiviral strategies. A few strong medications are under investigation, so we have to focus on proposals which ought to be taken to forestall this infection in a living host.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2217/fvl-2020-0124

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994

Show all 208 references

Research works printed but not linked: 4

10.1016/j.cell.2020.02.058 · DOI · Paper page
10.1101/2020.03.19.20039107v1 · DOI
Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV). www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-the-company-ongoing-response-to-the-2019-new-coronavirus
Liu W , LiH. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism 1 introduction. ChemRxiv11938173 (2020).

Sorted by citations

Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
“The fusion of two membranes is the crucial step before the virus enters the host cell [11, 12].”
Background
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Lazarević, I., Pravica, V., Miljanovic, D., & Cupic, M. D. (2021) · Viruses · doi:10.3390/v13071192 · Cited by 193
Covid‐19 and oral diseases: Crosstalk, synergy or association?
Brandini, D. A., Takamiya, A. S., Thakkar, P., Schaller, S. J., Rahat, R., & Naqvi, A. R. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2226 · Cited by 120
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Khan, A., Khan, T., Ali, S., Aftab, S., Wang, Y., Wang, Q., Khan, M., Suleman, M., Ali, S., Heng, W., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112176 · Cited by 75
Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies
Srivastav, S., Dankov, A., Adanalic, M., Grzeschik, R., Tran, V. T., Pagel‐Wieder, S., Gessler, F., Spreitzer, I., Scholz, T., Schnierle, B. S., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02305 · Cited by 71
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Li, X., Yuan, H., Li, X., & Wang, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28212 · Cited by 76
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
Khan, A., Gui, J., Ahmad, W., Haq, I., Shahid, M., Khan, A. A., Shah, A., Khan, A., Ali, L., Anwar, Z., et al. (2021) · RSC Advances · doi:10.1039/d1ra04694b · Cited by 68
Virus interactions with the actin cytoskeleton—what we know and do not know about SARS-CoV-2
Kloc, M., Uosef, A., Wosik, J., Kubiak, J. Z., & Ghobrial, R. M. (2022) · Archives of Virology · doi:10.1007/s00705-022-05366-1 · Cited by 64
Preliminary Structural Data Revealed That the SARS‐CoV‐2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity
Khan, A., Wei, D., Kousar, K., Abubaker, J. A., Ahmad, S., Ali, J., Al‐Mulla, F., Ali, S. S., Nizam‐Uddin, N., Sayaf, A. M., et al. (2021) · ChemBioChem · doi:10.1002/cbic.202100191 · Cited by 59
3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds
Joshi, R. P., Gebauer, N. W. A., Bontha, M., Khazaieli, M., James, R. M., Brown, J., & Kumar, N. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c06437 · Cited by 53
Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor
Suleman, M., Yousafi, Q., Ali, J., Ali, S. S., Hussain, Z., Ali, S., Waseem, M., Iqbal, A., Ahmad, S., Khan, A., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104936 · Cited by 49
The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
Nitika, Wei, J., & Hui, A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s341694 · Cited by 42
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877 · Cited by 31
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
Tiotiu, A. I., Chong‐Neto, H. J., Bikov, A., Kowal, K., Steiropoulos, P., Labor, M., Chérrez-Ojeda, I., Badellino, H., Emelyanov, A. V., Garcia, R., et al. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1951707 · Cited by 30
Viruses of the oral cavity: Prevalence, pathobiology and association with oral diseases
Thakkar, P., Banks, J. M., Rahat, R., Brandini, D. A., & Naqvi, A. R. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2311 · Cited by 36
Structural understanding of SARS-CoV-2 virus entry to host cells
Le, K. P. U., Kannappan, S., Kim, T., Lee, J. H., Lee, H.-R., & Kim, K. K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1288686 · Cited by 34
Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches
Shah, A., Rehmat, S., Aslam, I., Suleman, M., Batool, F., Aziz, A., Rashid, F., Midrarullah, Nawaz, M. A., Ali, S. S., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105170 · Cited by 30
Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2
Monje‐Galvan, V., & Voth, G. A. (2021) · Faraday Discussions · doi:10.1039/d1fd00031d · Cited by 28
Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study
Khan, A., Hussain, S., Ahmad, S., Suleman, M., Bukhari, I., Khan, T., Rashid, F., Azad, A. K., Waseem, M., Khan, W., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105163 · Cited by 25
All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes
Dutta, S., Panthi, B., & Chandra, A. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c00833 · Cited by 22
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
Titong, A., Kankanamalage, S. G., Dong, J., Huang, B. C. B., Spadoni, N., Wang, B., Wright, M., Pham, K. L. J., Le, A. H., & Liu, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-07952-4 · Cited by 21
[Epidemiology of HIV-associated malignancies].
Launay, O., & Guillevin, L. (2003) · PubMed · Cited by 22
A CRISPR/Cas12 trans-cleavage reporter enabling label-free colorimetric detection of SARS-CoV-2 and its variants
Kim, H., Jang, H., Song, J., Lee, S. M., Lee, S., Kwon, H., Kim, S., Kang, T., & Park, H. G. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116102 · Cited by 20
(+)-Usnic acid and its salts, inhibitors of SARS‐CoV‐2, identified by using in silico methods and in vitro assay
Oh, E., Wang, W., Park, K.-H., Park, C., Cho, Y., Lee, J., Kang, E., & Kang, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-17506-3 · Cited by 20
Recent Progress Using De Novo Design to Study Protein Structure, Design and Binding Interactions
Ferrando, J., & Solomon, L. A. (2021) · Life · doi:10.3390/life11030225 · Cited by 20
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Dumache, R., Enache, A., Macasoi, I. G., Dehelean, C. A., Dumitrascu, V. C., Mihailescu, A., Popescu, R., Vlad, M., Vlad, C. S., & Mureşan, C. O. (2022) · Pathogens · doi:10.3390/pathogens11050516 · Cited by 17
V483A: an Emerging Mutation Hotspot of SARS-CoV-2
Ashwaq, O., Manickavasagam, P., & Haque, S. M. (2021) · Future Virology · doi:10.2217/fvl-2020-0384 · Cited by 15
Self-citation
Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2
Upadhyay, M., & Gupta, S. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198897 · Cited by 18
Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases
Banks, J. M., Capistrano, K. J., Brandini, D. A., Zaidi, F., Thakkar, P., Rahat, R., Schwartz, J., & Naqvi, A. R. (2024) · Pathogens · doi:10.3390/pathogens13010058 · Cited by 14
From Emergence to Endemicity: A Comprehensive Review of COVID-19
Naik, R., Avula, S., Palleti, S. K., Gummadi, J., Ramachandran, R., Chandramohan, D., Dhillon, G. S., Gill, A. S., Paiwal, K., Shaik, B. F., et al. (2023) · Cureus · doi:10.7759/cureus.48046 · Cited by 17
The Bright and Dark Sides of Reactive Oxygen Species Generated by Copper–Peptide Complexes
Komarnicka, U. K., Lesiów, M. K., Witwicki, M., & Bieńko, A. (2022) · Separations · doi:10.3390/separations9030073 · Cited by 12
Looking for SARS-CoV-2 Therapeutics Through Computational Approaches
Vincenzi, M., Mercurio, F. A., & Leone, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221004104430 · Cited by 13
Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials
Aljuhani, A., Albalawi, O., Albalawi, R., Alsalama, R., Alatawi, S., Altemani, R., Abdel‐Maksoud, M. S., & Elsherbiny, N. (2023) · Cell Biology International · doi:10.1002/cbin.12014 · Cited by 12
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
Demoliou, C. D., Papaneophytou, C. P., & Nicolaidou, V. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73134 · Cited by 12
Identification of Plant-Based Drug-like Molecules as Potential Inhibitors against hACE2 and S-RBD of SARS-CoV-2 using Multi-step Molecular Docking and Dynamic Simulation Approach.Preprint
Parihar, A., Sonia, Z. F., Choudhary, N. K., Sharma, P., Mahdi, I., Hakim, F. T., Ali, M., Khan, R., Alqahtan, M. S., & Abbas, M. A. E. (2022) · Research Square · doi:10.21203/rs.3.rs-1517448/v1 · Cited by 11
The vital role of animal, marine, and microbial natural products against COVID-19
Alqathama, A. A., Ahmad, R., Alsaedi, R. B., Alghamdi, R. A., Abkar, E. H., Alrehaly, R. H., & Abdalla, A. N. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2039215 · Cited by 10
Rapid and simultaneous detection of SARS-CoV-2 and influenza A using vertical flow assay based on AAO and SERS nanotags
Yu, L., Fei, R., Zhang, J., Zhu, G., Mo, X., Wan, Y., Huang, Y., Sun, Q., Meng, D., & Zhao, X. (2023) · Sensors & Diagnostics · doi:10.1039/d3sd00118k · Cited by 9
Cyanobacteria and their metabolites - can they be helpful in the fight against pathogenic microbes?
Grabowski, Ł., Wiśniewska, K., Żabińska, M., Konarzewska, M., Zielenkiewicz, M., Rintz, E., Cyske, Z., Gaffke, L., Pierzynowska, K., Mazur‐Marzec, H., et al. (2024) · Blue Biotechnology · doi:10.1186/s44315-024-00003-9 · Cited by 8
Prospects of Using Machine Learning and Diamond Nanosensing for High Sensitivity SARS-CoV-2 Diagnosis
Qureshi, S. A., Aman, H., & Schirhagl, R. (2023) · Magnetochemistry · doi:10.3390/magnetochemistry9070171 · Cited by 8
Lactoferrin Binds through Its N-Terminus to the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
Babulic, P., Cehlár, O., Ondrovičová, G., Moskalets, T., Škrabana, R., & Leksa, V. (2024) · Pharmaceuticals · doi:10.3390/ph17081021 · Cited by 8
Localization-based super-resolution microscopy reveals relationship between SARS-CoV2 spike and phosphatidylinositol (4,5): biphosphate
Raut, P., Waters, H. N., Zimmerberg, J. J., Obeng, B., Gosse, J. A., & Hess, S. T. (2022) · Multiphoton Microscopy in the Biomedical Sciences · doi:10.1117/12.2613460 · Cited by 10
Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Cottignies-Calamarte, A., Marteau, F., He, F., Belouzard, S., Dubuisson, J., Tudor, D., Viollet, B., & Bomsel, M. (2025) · Journal of Virology · doi:10.1128/jvi.00394-25 · Cited by 6
Does test anxiety and gender have an impact on OSCE Performance among medical students?
Arain, F. R. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94165 · Cited by 6
Insights into the Binding of Receptor-Binding Domain (RBD) of SARS-CoV-2 Wild Type and B.1.620 Variant with hACE2 Using Molecular Docking and Simulation Approaches
Muhseen, Z. T., Kadhim, S., Yahiya, Y. I., Alatawi, E. A., Alkhayl, F. F. A., & Almatroudi, A. (2021) · Biology · doi:10.3390/biology10121310 · Cited by 6
Current challenges in different approaches to control COVID-19: a comprehensive review
Giri, S., Sen, S., Singh, R., Paul, P., Sahu, R., Nandi, G., & Dua, T. K. (2022) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-022-00730-2 · Cited by 6
Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases
Nguyen, H. O., Tiberio, L., Facchinetti, F., Ripari, G., Violi, V., Villetti, G., Salvi, V., & Bosisio, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092254 · Cited by 6
Portable DNA Probe Detector and a New Dry-QCM Approach for SARS-CoV-2 Detection
Munthala, D., Sonklin, T., Chanlek, N., Mathur, A. K., Roy, S., Avasthi, D. K., Suksaweang, S., & Pojprapai, S. (2025) · Technologies · doi:10.3390/technologies13030114 · Cited by 5
Computational Analysis Predicts Correlations among Amino Acids in SARS-CoV-2 Proteomes
Broni, E., & Miller, W. A. (2023) · Biomedicines · doi:10.3390/biomedicines11020512 · Cited by 5
Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics
Selvaraj, C., Dinesh, D. C., Krafčíková, P., Bouřa, E., Aarthy, M., Pravin, M. A., & Singh, S. K. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210906125959 · Cited by 5
Computational Analysis of Short Linear Motifs in the Spike Protein of SARS-CoV-2 Variants Provides Possible Clues into the Immune Hijack and Evasion Mechanisms of Omicron Variant
Soorajkumar, A., Alakraf, E., Uddin, M. J., du Plessis, S. S., Alsheikh-Ali, A. A. A., & Kandasamy, R. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158822 · Cited by 5
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
Schmidt, J., Berghaus, S., Blessing, F., Wenzel, F., Herbeck, H., Blessing, J., Schierack, P., Rödiger, S., & Roggenbuck, D. (2021) · GeroScience · doi:10.1007/s11357-021-00443-w · Cited by 4
Non-neutralizing antibodies against SARS-CoV-2 nucleocapsid protein mediate variant transcendent antibody-dependent cellular cytotoxicity
Osuagwu, A. E., Payne, M., Bosch, J., Mbonye, U. R., Nguyen, K., Karn, J., Bruchez, A. M., & King, C. L. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf123 · Cited by 3
Accelerating the discovery of the beyond rule of five compounds that have high affinities toward SARS-CoV-2 spike RBD
Abu‐Saleh, A. A. A., Yadav, A., & Poirier, R. A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2036640 · Cited by 3
Drug Repurposing For SARS-COV-2 Using Molecular Docking
Aqeel, I., Majid, A., Ismail, M. I., & Bashir, H. (2022) · International Bhurban Conference on Applied Sciences and Technology (IBCAST) · doi:10.1109/ibcast54850.2022.9990466 · Cited by 3
The social, psychological, and physical impact of COVID-19 restrictions for institutionalized adults with intellectual and developmental disabilities
Bösebeck, F., Worthmann, H., Möller, C., & Konrad, C. (2023) · Journal of Intellectual Disabilities · doi:10.1177/17446295231168293 · Cited by 3
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability
Debnath, S. K., Debnath, M., Srivastava, R., & Omri, A. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2082944 · Cited by 3
SARS-CoV-2 virus: origin, structure and replication cycle
Kuczyńska, K., Zawilska, J. B., Badura, J., & Strehl, B. (2021) · Farmacja Polska · doi:10.32383/farmpol/135222 · Cited by 3
SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey
Carro, B. (2021) · All Life · doi:10.1080/26895293.2021.1977186 · Cited by 2
Prevalence and Associated Factors of Diabetic ketoacidosis among Patients Living with Type 1 Diabetes in Makkah Al-Mukarramah City
Alhajaji, R., Almasodi, K., Alhajaji, A., Alturkstani, A., & Samkari, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94154 · Cited by 3
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v21 · Cited by 3
COVID-19: From Emergence to Endemicity - A Comprehensive ReviewPreprint
Naik, R., Avula, S., Palleti, S. K., Gummadi, J., Ramachandran, R., Chandramohan, D., Dhillon, G. S., Gill, A. S., Paiwal, K., Shaik, B. F., et al. (2023) · Preprints.org · doi:10.20944/preprints202307.0699.v1 · Cited by 3
Viruses in gastrointestinal cancers: Molecular pathogenesis, oncogenic mechanisms, and translational perspectives
Liu, B., Liu, C., Sunggip, C., Pu, G., & Deng, D. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101415 · Cited by 2
Identification of interaction partners using protein aggregation and NMR spectroscopy
Chae, Y. K., Shin, H. B., & Woo, T. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270058 · Cited by 2
Comparison of Body Image Perception and Depression in Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women
Kanwal, S., Fatima, S. S., Abid, F., Jafri, A., Kazmi, F. H., & Fatima, N. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94163 · Cited by 2
All ‐atom simulations of the trimeric spike protein of SARS‐CoV ‐2 in aqueous medium: Nature of interactions, conformational stability and free energy diagrams for conformational transition of the protein
Panthi, B., Dutta, S., & Chandra, A. (2023) · Journal of Computational Chemistry · doi:10.1002/jcc.27108 · Cited by 2
Deciphering the complexity of COVID-19 transmission: Unveiling precision through robust vaccination policies and advanced predictive modeling with random forest regression
Kooptiwoot, S., Tharasawatpipat, C., Choo-In, S., Kayee, P., Meethongjan, K., Sangsuwon, C., & Javadi, B. (2024) · Journal of Infrastructure Policy and Development · doi:10.24294/jipd.v8i8.5321 · Cited by 2
A Search for Sars‐CoV‐2 Main Protease Inhibitors: Synthesis and Docking Study of Steroidal Dinitriles
Nikolić, A. R., Kuzminac, I. Z., Petri, E. T., Ćelić, A. S., & Sakač, M. N. (2024) · ChemistrySelect · doi:10.1002/slct.202304164 · Cited by 1
Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice
Wang, S., Ren, L., Liu, Y., Shen, X., Hao, Y., & Shao, Y. (2024) · Future Virology · doi:10.2217/fvl-2023-0212 · Cited by 1
Cigarette smoke as a superspreading vector of SARS-CoV-2, measles virus, and influenza virus: A hypothesis on virus-laden aerosol formation and transport
Kim, D. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111757 · Cited by 1
Genetics and Biological Characteristics of SARS-CoV-2
Norouzi, M., Miles, M. A., & Norouzi, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_4 · Cited by 2
Diagnosing COVID-19: diagnostic importance of detectingEgene of the SARS-CoV-2 genome
Barjaktarović, I., Maletić, J. S., Vučinić, N., Milutinović, A., Grujičić, M., & Čabarkapa, V. (2023) · Future Virology · doi:10.2217/fvl-2021-0330 · Cited by 1
Computational Drug Design Strategies for Fighting the COVID-19 Pandemic
Hakmi, M., Bouricha, E. M., Soussi, A., Bzioui, I. A., Belyamani, L., & Ibrahimi, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-61939-7_11 · Cited by 1
Prevention of developmental delays among children at public healthcare facilities of Pakistan: protocol for a cluster Randomized Controlled Trial
Khan, N., Khan, M. A., Khan, M. A., Ejaz, A., Warraitch, A., & Khan, H. J. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94156 · Cited by 1
The Trend of Four Consultation Models in Four Specialties at Four Tertiary Care Hospitals
Abdulghani, H. M., Sattar, K., Karim, S. I., Ahmad, T., Akram, A., Alsalem, R., Alruwaite, M., Alkhraiji, N., Al-Ghamdi, G. M., & Alkhulaifi, A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94153 · Cited by 1
Factors Associated with Not Continuing Initiated Breastfeeding among Saudi Females in Abha
Mandoura, Y. T., Alsaleh, M., & Alsaleem, S. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94164 · Cited by 1
Impact of Covid-19 on asthmatic patients in Western region in Saudi Arabia
AlGhamdi, A. N. Z., Albaqami, A. M., Abdullah, A. M., Alsukhayri, D. A., Alawi, H. A., & Baabbad, A. S. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94161 · Cited by 1
COVID-19 in India
Sharma, S. (2021) · Journal of Public Health and Primary Care · doi:10.4103/jphpc.jphpc_10_21 · Cited by 1
A REVIEW ON THE DEVELOPMENT OF FAVIPRAVIR AGAINST SARS COV 2 INFECTION
VINOD, B. (2022) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2022v14i2.1957 · Cited by 1
Coronavirus Pandemic: A Review of Different Machine Learning Approaches
Singh, B. P., & Agarwal, R. (2022) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-16-7610-9_18 · Cited by 1
Immune system response to the Covid 19 virus and 3rd boosters
Spigelman, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94159 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v35 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v30 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v15 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-l393t-v33 · Cited by 1
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v32
Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v35
Knowledge, Attitude and Awareness towards Corneal Donation in Aseer Region, Saudi Arabia
Alamri, A., Alqahtani, F. M., Alqahtani, H. A., Alqahtani, M., Alqahtani, M. M., Shibli, M. A. A., & Almastour, R. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94162
Clinical Efficacy and Cholesterol-Lowering Effects of Inclisiran
bin Daud, M. D. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94166
Non-surgical options to treat androgenic alopecia
Abdalla, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94168
Impact of COVID-19 on patients receiving chemotherapy for gynecological cancer
Andijani, M. N., Alibrahim, A. O., Tmraz, S. F., ALshenqity, L. F., Alaama, A. S., Zaatari, B. A., Anfinan, N. M., & Sait, K. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94158
A retrospective study of thyroid hormone in Pediatrics: relationships with growth hormone correlation with effects of diabetes in Riyadh, Saudi Arabia
AlShareef, F., Al-Faris, A., Alhafez, N. A., Albulosh, A. S., Aljuhni, A., Almahmoud, K. A., Almajdui, M. A., Alswayed, K. E., Alghuraybi, S. I., Alomary, S. A., et al. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94157
Gender differences of the clinical aspects and complication risks of diabetes mellitus among outpatient clinic visits, Jeddah, Saudi Arabia
El-Gamal, F., Aljudaibi, A., Alzahrani, A., Alharthy, L., & Huwait, T. A. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94155
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v31
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v33
Accelerating the Discovery of the Beyond Rule of Five Compounds That Have High Affinities Toward SARS-CoV-2 Spike RBDPreprint
Abu‐Saleh, A. A. A., Yadav, A., & Poirier, R. A. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14130353
Malignant Melanoma
Abdalla, M. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94167
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v19
Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?Preprint
Datta, S. (2021) · doi:10.33774/chemrxiv-2021-l393t-v36
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v20
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v25

Authors: Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K.
Affiliations: Jubail Industrial College (SA)
Department of Chemical & Process Engineering Technology Jubail Industrial College P. O. Box 10099 Jubail Industrial City 31961 Saudi Arabia
Corresponding author: Haque, SK Manirul
ORCID: Haque, SK Manirul
Ashwaq, Omar
Sarief, Abdulla
Azad John Mohamed, Abdul Kalam
Venue: Future Virology
Publisher: Informa UK Limited
Published: 2020-09
Volume: 15
Issue: 9
Pages: 625-648
ISSN: 1746-0794 (ISSN-L)
1746-0808
DOI: 10.2217/fvl-2020-0124
PMC: PMC7664148
OpenAlex: W3096912664
Cited by: 121
References: 208
Citations by year: 2025: 6 · 2024: 10 · 2023: 15 · 2022: 25 · 2021: 62 · 2020: 2
FWCI: 1.23
Type: journal article
Language: en
Update notices: correction (2021-07-08)
Open access: green
www.ncbi.nlm.nih.gov
Locations: Future Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords: SARS-CoV-2, COVID-19 pandemic, SARS-CoV, MERS-CoV, ACE2 receptor, host-virus interaction, respiratory transmission, clinical symptoms, antiviral strategies, prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Comprehensive Review About SARS-CoV-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks